Transaction · 0001822629-26-000002

Lalwani Nikhil

Lalwani Nikhil, PRES, CEO, reported a transaction classified as withholding at ANI PHARMACEUTICALS INC involving 30659.000000 shares for an estimated $2337748.75. Reported holdings after the transaction were 380560.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

withholdingSEC transaction code FPRES, CEO
ANIPANI PHARMACEUTICALS INC
Filing timeFeb 13
Trade dateFeb 11, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$77.36
Pre-filing
1mo ago +9.0%1w ago +5.1%1d ago +3.3%
Returns since
7d +0.5%30d -8.9%90d +2.9%180d -2.9%1y -4.5%

ANIP price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ANIP since 2026-02-13Filed 203 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
withholding
Code F
Identifier
0001822629-26-000002
Common Stock
Transaction date
Feb 11, 2026
Filed Feb 13, 2026, 09:09 PM · 2d delay
Shares
30.6k sh
$7.62k per share
Estimated value
-$233M
Computed from shares × price
Holdings after
380k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-12score
Filing-only score

-12

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

PRESIDENT & CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 63,686 performance stock units, the grant of which was previously reported on April 6, 2023.

Original filing · 0001822629-26-000002
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ANIP